Pentwater Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$185K 133
2019
Q4
$185K Sell
10,000
-9,100
-48% -$168K ﹤0.01% 102
2019
Q3
$265K Sell
19,100
-2,000
-9% -$27.7K ﹤0.01% 102
2019
Q2
$309K Buy
+21,100
New +$309K ﹤0.01% 111